Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • Specialties
  • Diabetes & Endocrinology
  • Page 22
Veligrotug Emerges as a Promising Therapy for Thyroid Eye Disease: Insights from the THRIVE and THRIVE-2 Trials
Posted inClinical Updates Diabetes & Endocrinology news Ophthalmology Specialties

Veligrotug Emerges as a Promising Therapy for Thyroid Eye Disease: Insights from the THRIVE and THRIVE-2 Trials

Posted by MedXY By MedXY 07/31/2025
Veligrotug demonstrates robust efficacy and manageable safety in both active and chronic thyroid eye disease, positioning itself as a potential alternative to teprotumumab based on phase 3 THRIVE trial data.
Read More
GLP-1 Receptor Agonists and Risk of GERD in Type 2 Diabetes: Clinical Implications from a Large Population-Based Cohort Study
Posted inClinical Updates Diabetes & Endocrinology Gastroenterology news Specialties

GLP-1 Receptor Agonists and Risk of GERD in Type 2 Diabetes: Clinical Implications from a Large Population-Based Cohort Study

Posted by MedXY By MedXY 07/31/2025
GLP-1 receptor agonists modestly increase the risk of GERD and its complications compared to SGLT-2 inhibitors in type 2 diabetes patients, highlighting the need for vigilant symptom monitoring.
Read More
Weekend Warrior Exercise Patterns: Comparable Cardiometabolic Protection to Regular Activity in Diabetes and MASLD
Posted inClinical Updates Diabetes & Endocrinology news Specialties

Weekend Warrior Exercise Patterns: Comparable Cardiometabolic Protection to Regular Activity in Diabetes and MASLD

Posted by MedXY By MedXY 07/31/2025
Accumulating 150 minutes of moderate-to-vigorous physical activity weekly, either as a 'weekend warrior' or in regular sessions, significantly reduces mortality and cardiometabolic risk in adults with diabetes and MASLD.
Read More
GLP-1 Receptor Agonists and Dementia Risk in Older Adults With Type 2 Diabetes: Insights From a Target Trial Emulation
Posted inClinical Updates Diabetes & Endocrinology news Specialties

GLP-1 Receptor Agonists and Dementia Risk in Older Adults With Type 2 Diabetes: Insights From a Target Trial Emulation

Posted by MedXY By MedXY 07/31/2025
A large-scale emulated trial found no clear overall reduction in dementia risk with GLP-1 receptor agonists versus DPP-4 inhibitors in older adults with type 2 diabetes, though age-specific effects warrant further investigation.
Read More
Preterm Birth Linked to Long-Term Adult Cardiometabolic and Mental Health Risks: New U.S. Cohort Study
Posted inCardiology Diabetes & Endocrinology Medical News news Specialties

Preterm Birth Linked to Long-Term Adult Cardiometabolic and Mental Health Risks: New U.S. Cohort Study

Posted by MedXY By MedXY 07/30/2025
Adults born preterm face significantly higher risks of cardiometabolic abnormalities and internalizing mental health problems by age 35, according to a new U.S. cohort study.
Read More
Top U.S. Hospitals for Diabetes and Endocrinology: Interpreting the 2025–2026 U.S. News Rankings
Posted inDiabetes & Endocrinology Medical News news Specialties

Top U.S. Hospitals for Diabetes and Endocrinology: Interpreting the 2025–2026 U.S. News Rankings

Posted by MedXY By MedXY 07/30/2025
A critical analysis of the 2025–2026 U.S. News rankings for diabetes and endocrinology care, examining methodology, clinical impact, and implications for patient care and referral.
Read More
Redefining Obesity: Impact of the ‘Clinical Obesity’ Framework on Global Prevalence Estimates
Posted inCardiology Diabetes & Endocrinology Medical News news Specialties

Redefining Obesity: Impact of the ‘Clinical Obesity’ Framework on Global Prevalence Estimates

Posted by MedXY By MedXY 07/30/2025
A new, function-driven definition of “clinical obesity” dramatically lowers global obesity prevalence rates compared to BMI-based estimates, raising implications for disease surveillance, prevention, and healthcare policy.
Read More
Understanding Macronutrients: Their Role in Obesity and Weight Management
Posted inCardiology Diabetes & Endocrinology news Specialties

Understanding Macronutrients: Their Role in Obesity and Weight Management

Posted by MedXY By MedXY 07/29/2025
Explore the impact of macronutrients on obesity, focusing on carbohydrates, proteins, and fats, and learn strategies for effective weight management.
Read More
Revolutionizing Diabetes Management in Pregnancy with Hybrid Closed-Loop Technology
Posted inDiabetes & Endocrinology news OB/GYN & Women's Health Specialties

Revolutionizing Diabetes Management in Pregnancy with Hybrid Closed-Loop Technology

Posted by MedXY By MedXY 07/29/2025
A groundbreaking trial highlights how hybrid closed-loop systems improve glycemic control for pregnant women with type 1 diabetes, offering enhanced maternal and fetal health outcomes.
Read More
Maternal Diet and Childhood Diabetes: Unveiling the Link
Posted inDiabetes & Endocrinology news Specialties

Maternal Diet and Childhood Diabetes: Unveiling the Link

Posted by MedXY By MedXY 07/29/2025
A large Danish study reveals that pro-inflammatory diets during pregnancy may increase the risk of type 1 diabetes in offspring, emphasizing the importance of maternal nutrition.
Read More
Gut Microbiota and Gestational Diabetes: A Critical Connection
Posted inDiabetes & Endocrinology news OB/GYN & Women's Health Specialties

Gut Microbiota and Gestational Diabetes: A Critical Connection

Posted by MedXY By MedXY 07/29/2025
New research highlights links between gut microbiota composition and gestational diabetes, offering potential for early detection and personalized treatment strategies.
Read More
New Diabetes Guidelines Spotlight Preconception Care for Women
Posted inDiabetes & Endocrinology news Specialties

New Diabetes Guidelines Spotlight Preconception Care for Women

Posted by MedXY By MedXY 07/29/2025
Comprehensive guidelines emphasize preconception care for women with diabetes to reduce pregnancy risks and improve maternal and infant health.
Read More
Enhanced Weight Loss for Menopausal Women: The Role of Tirzepatide and Hormone Therapy
Posted inDiabetes & Endocrinology news OB/GYN & Women's Health Specialties

Enhanced Weight Loss for Menopausal Women: The Role of Tirzepatide and Hormone Therapy

Posted by MedXY By MedXY 07/29/2025
A new study reveals combining tirzepatide and hormone therapy significantly boosts weight loss in postmenopausal women, offering a promising approach to managing obesity-related health risks.
Read More
The Rise of Ozempic and Wegovy: Revolutionizing Weight Loss, But At What Cost?
Posted inDiabetes & Endocrinology news Specialties

The Rise of Ozempic and Wegovy: Revolutionizing Weight Loss, But At What Cost?

Posted by MedXY By MedXY 07/28/2025
Semaglutide drugs like Ozempic and Wegovy are transforming obesity treatment, but questions remain about long-term safety, access, and societal impact.
Read More
Ozempic and the Weight Loss Revolution: Miracle Drug or Medical Hype?
Posted inCardiology Diabetes & Endocrinology news

Ozempic and the Weight Loss Revolution: Miracle Drug or Medical Hype?

Posted by MedXY By MedXY 07/28/2025
Exploring the science, benefits, risks, and realities behind Ozempic and other GLP-1 drugs in the fight against obesity.
Read More
Eating Eggs Weekly May Lower Risks of Diabetes and Hypertension
Posted inCardiology Diabetes & Endocrinology news Specialties

Eating Eggs Weekly May Lower Risks of Diabetes and Hypertension

Posted by MedXY By MedXY 07/27/2025
Recent research suggests that consuming five or more eggs weekly may reduce the risks of diabetes and hypertension, offering a healthier outlook for balanced diets.
Read More
Gestational Diabetes: Essential Strategies for a Healthy Pregnancy and Baby
Posted inDiabetes & Endocrinology news OB/GYN & Women's Health Specialties

Gestational Diabetes: Essential Strategies for a Healthy Pregnancy and Baby

Posted by MedXY By MedXY 07/27/2025
Discover the crucial details gestational diabetes patients must manage to protect fetal health, informed by science and expert recommendations.
Read More
Pregnancy and Diabetes: What Every Patient Needs to Know for a Healthy Journey
Posted inDiabetes & Endocrinology news OB/GYN & Women's Health Specialties

Pregnancy and Diabetes: What Every Patient Needs to Know for a Healthy Journey

Posted by MedXY By MedXY 07/27/2025
Discover the key precautions and expert advice for women with diabetes considering pregnancy, blending the latest science with real-life advice.
Read More
Staying Active with Diabetes: What You Need to Know Before You Exercise
Posted inDiabetes & Endocrinology news Specialties

Staying Active with Diabetes: What You Need to Know Before You Exercise

Posted by MedXY By MedXY 07/27/2025
Discover how people with diabetes can exercise safely and effectively by understanding key considerations, evidence-based practices, and expert advice.
Read More
Zero-Sugar, Zero-Calorie Drinks: Can You Really Drink Them Freely While Dieting?
Posted inDiabetes & Endocrinology Family Medicine & Nutrition news Specialties

Zero-Sugar, Zero-Calorie Drinks: Can You Really Drink Them Freely While Dieting?

Posted by MedXY By MedXY 07/26/2025
Are zero-sugar, zero-calorie drinks a dieter's dream or a hidden trap? We unpack the science, misconceptions, and practical advice for healthy weight management.
Read More

Posts pagination

Previous page 1 … 20 21 22 23 Next page
  • Survival Unaffected by Surgical Complications in Advanced Esophageal Cancer: A JCOG1109 Exploratory Analysis
  • Peritoneal Cancer Risk After Risk-Reducing Salpingo-Oophorectomy: The Impact of BRCA Mutational Status and STIC Lesions
  • One-Hour Plasma Glucose: A Vital Predictor of Cardiometabolic Risk in Women with PCOS
  • The Shift Toward De-escalation: Why Radical Trachelectomy Is Losing Ground in Early-Stage Cervical Cancer
  • Management of Endometrial Polyps: A Synthesis of Modern Diagnostic and Therapeutic Strategies
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular health cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology exercise health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality nutrition obesity older adults oncology Pediatrics Physical Activity precision medicine Pregnancy prevention prostate cancer public health randomized clinical trial randomized trial SGLT2 inhibitors stroke targeted therapy type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in